Alan Ezrin

Previous co-founder of Cardiome Pharma and ConjuChem, both of which matured from start-up stage to multi-hundred million dollar market cap firms under his scientific and business leadership.

Dr. Ezrin has 35+ years of experience in research and business development in both the pharmaceutical/biotechnology sectors in the US & Canada. He holds a Ph.D. in pharmacology from the University of Miami, and serves on the Board of NX PharmaGen and on the Board of Advisors for the Preston Robert Tisch Brain Tumor Center at Duke University.